Koyfin Home > Directory > Health Care > Accelerate Diagnosti > Gross Margin

Accelerate Diagnosti Gross Margin Chart (AXDX)

Accelerate Diagnosti annual/quarterly Gross Margin from 2010 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Accelerate Diagnosti Gross Margin for the quarter ending June 06, 2020 was $45m a -13.19% decrease of -6m year over year
  • Accelerate Diagnosti Gross Margin for the last 12 months ending June 06, 2020 was $46m a 2.63% increase of 1m year over year
  • Accelerate Diagnosti Annual Gross Margin for 2019 was $47m a 7.47% increase of 4m from 2018
  • Accelerate Diagnosti Annual Gross Margin for 2018 was $44m a -73.57% decrease of -32m from 2017
  • Accelerate Diagnosti Annual Gross Margin for 2017 was $76m a -31.56% decrease of -24m from 2016
Other Margins & Efficiency Metrics:
  • Accelerate Diagnosti EBITDA Margin for the quarter ending October 10, 2011 was $-181m a 102.85% decrease of -186m year over year
  • Accelerate Diagnosti Return on Capital % for the quarter ending September 09, 2018 was -23.88 a -35.88% increase of 8.57 year over year
  • Accelerate Diagnosti Return on Equity % for the quarter ending September 09, 2018 was -102.61 a 48.90% decrease of -50.18 year over year
View Chart On Koyfin

Quarterly AXDX Gross Margin Data

06/2020$45m
03/2020$45m
12/2019$44m
09/2019$51m
06/2019$50m
03/2019$48m
12/2018$29m
09/2018$50m
06/2018$58m
03/2018$39m

Annual AXDX Gross Margin Data

2019$47m
2018$44m
2017$76m
2016$100m
2015$100m
2014$100m
2013$100m
2012$100m
2012$100m
2011$100m